Peptide Current
Home/Compounds/AOD-9604
Weight Loss
Emerging

AOD-9604

GH fragment

A GH-fragment weight-loss compound that keeps showing up in fat-loss research and protocol-driven search demand.

Abstract molecular artwork for AOD-9604
EVIDENCEEmerging
DELIVERYInjection · Oral
PRICE RANGE
PRODUCTS0 Verified
ARTICLES2 Published

How It Works

AOD-9604 is designed to focus on the fat-mobilization side of growth-hormone signaling without reproducing the full endocrine profile of HGH.

Practical Information

injection

AOD-9604 is often marketed as an injectable protocol compound, but practical coverage should separate that market format from the more limited human evidence base.

oral

Oral AOD-9604 matters because human study history includes oral administration, even though consumer search demand often drifts toward injectable peptide-market protocols.

See all 2 articles
A confident adult on a bright morning walk, holding a water bottle and settling into a weight-loss routine without dramatic gym imagery.

AOD-9604 Dosage: What Human Trials Really Showed

The AOD-9604 dosage question is clearest when you stick to clinical evidence: once-daily oral regimens in real human trials, followed by a larger study that changed everything. Here's what actually moved the needle.

4 min read

AOD-9604: What It Promises for Fat-Loss Progress

AOD-9604: What It Promises for Fat-Loss Progress

AOD-9604 keeps showing up because the idea is attractive: a narrower fat-loss peptide with less of the GLP-1 routine and a lower out-of-pocket barrier. This guide explains what it is, what the human evidence actually shows, and why the price-and-proof picture still keeps it on the fringe.

4 min read